A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. The Multiple Sclerosis Collaborative Research Group. - Simon,J.H.; Lull,J.; Jacobs,L.D. (Neurology, 2000)